Jaguar Gene Therapy Announces Preclinical Data Presentations at Upcoming American Society of Gene an
- Accepted abstracts include preclinical data on JAG101, an investigational gene therapy designed to address the root cause of Type 1 galactosemiaLAKE FOREST, Ill.--(BUSINESS WIRE)--Jaguar Gene Therapy, a biotechnology company accelerating breakthroughs in gene therapy for patients suffering from severe genetic dise...
Source: pharmiweb.com